Abstract
Clinicians grappling with the enormous task of monitoring patients with acute decompensated heart failure (ADHF) in the hospital and the clinic would be very appreciative, had a reliable (i.e., sensitive and specific) biomarker was at hand, to be implemented. Unfortunately, such a biomarker has not emerged so far.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
